BioCentury | Jan 8, 2021
Finance

Jan. 8 Quick Takes: Venture rounds for Abbisko, DiCE, Aulos, LifeMine, Mana, Theolytics and more

...company Abbisko Therapeutics Co. Ltd. raised $123 million in a series D round led by the Carlyle Group...
BioCentury | Apr 11, 2019
Company News

Management tracks: Prime, Flexion, NodThera, Imara

...office. Marchick was managing director and global head of external affairs at asset management firm The Carlyle Group...
BioCentury | Jun 22, 2016
Financial News

Wu joins Carlyle Group

The Carlyle Group (NASDAQ:CG) named Jesse Wu senior advisor to its Asia buyout team. Wu was chairman of the China unit of Johnson & Johnson (NYSE:JNJ). BC Staff...
BioCentury | May 6, 2015
Financial News

Financial tracks

...Alternative asset management firm The Carlyle Group (NASDAQ:CG) named Jose Almeida an operating executive in its global heathcare...
BioCentury | Sep 1, 2014
Company News

Astute, Ortho-Clinical Diagnostics deal

...for use on Astute140 in all markets and will collaborate with Ortho-Clinical to market NephroCheck. The Carlyle Group...
BioCentury | Aug 18, 2014
Company News

J&J, The Carlyle Group deal

...In June, Johnson & Johnson said asset manager The Carlyle Group completed the acquisition of the pharma's Ortho-Clinical...
...BioCentury, Jan. 20, 2014 & April 7, 2014). Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. The Carlyle Group...
BioCentury | Apr 7, 2014
Company News

J&J, The Carlyle Group deal

...Johnson & Johnson accepted a binding offer from asset manager The Carlyle Group to acquire the pharma's Ortho-Clinical...
...BioCentury, Jan. 28, 2013 & Jan. 20, 2014). Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. The Carlyle Group...
BioCentury | Mar 31, 2014
Company News

Carlyle Group to acquire J&J's Ortho-Clinical Diagnostics business

...Johnson & Johnson (NYSE:JNJ) accepted a binding offer from asset manager The Carlyle Group to acquire the pharma's...
BioCentury | Mar 10, 2014
Company News

J&J management update

...chairman of Johnson & Johnson's Ortho-Clinical Diagnostics Inc. business, a newly created position, effective when The Carlyle Group...
BioCentury | Jan 20, 2014
Company News

J&J, The Carlyle Group deal

...Johnson & Johnson received a binding offer from asset manager The Carlyle Group to acquire the pharma's Ortho-Clinical...
...for Ortho-Clinical Diagnostics (see BioCentury, Jan. 28, 2013). Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. The Carlyle Group...
Items per page:
1 - 10 of 21
BioCentury | Jan 8, 2021
Finance

Jan. 8 Quick Takes: Venture rounds for Abbisko, DiCE, Aulos, LifeMine, Mana, Theolytics and more

...company Abbisko Therapeutics Co. Ltd. raised $123 million in a series D round led by the Carlyle Group...
BioCentury | Apr 11, 2019
Company News

Management tracks: Prime, Flexion, NodThera, Imara

...office. Marchick was managing director and global head of external affairs at asset management firm The Carlyle Group...
BioCentury | Jun 22, 2016
Financial News

Wu joins Carlyle Group

The Carlyle Group (NASDAQ:CG) named Jesse Wu senior advisor to its Asia buyout team. Wu was chairman of the China unit of Johnson & Johnson (NYSE:JNJ). BC Staff...
BioCentury | May 6, 2015
Financial News

Financial tracks

...Alternative asset management firm The Carlyle Group (NASDAQ:CG) named Jose Almeida an operating executive in its global heathcare...
BioCentury | Sep 1, 2014
Company News

Astute, Ortho-Clinical Diagnostics deal

...for use on Astute140 in all markets and will collaborate with Ortho-Clinical to market NephroCheck. The Carlyle Group...
BioCentury | Aug 18, 2014
Company News

J&J, The Carlyle Group deal

...In June, Johnson & Johnson said asset manager The Carlyle Group completed the acquisition of the pharma's Ortho-Clinical...
...BioCentury, Jan. 20, 2014 & April 7, 2014). Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. The Carlyle Group...
BioCentury | Apr 7, 2014
Company News

J&J, The Carlyle Group deal

...Johnson & Johnson accepted a binding offer from asset manager The Carlyle Group to acquire the pharma's Ortho-Clinical...
...BioCentury, Jan. 28, 2013 & Jan. 20, 2014). Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. The Carlyle Group...
BioCentury | Mar 31, 2014
Company News

Carlyle Group to acquire J&J's Ortho-Clinical Diagnostics business

...Johnson & Johnson (NYSE:JNJ) accepted a binding offer from asset manager The Carlyle Group to acquire the pharma's...
BioCentury | Mar 10, 2014
Company News

J&J management update

...chairman of Johnson & Johnson's Ortho-Clinical Diagnostics Inc. business, a newly created position, effective when The Carlyle Group...
BioCentury | Jan 20, 2014
Company News

J&J, The Carlyle Group deal

...Johnson & Johnson received a binding offer from asset manager The Carlyle Group to acquire the pharma's Ortho-Clinical...
...for Ortho-Clinical Diagnostics (see BioCentury, Jan. 28, 2013). Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. The Carlyle Group...
Items per page:
1 - 10 of 21